Iowa gambling task impairment in Parkinson's disease can be normalised by reduction of dopaminergic medication after subthalamic stimulation

Background Impulse control disorders (ICD), including pathological gambling, are common in Parkinson's disease (PD) and tend to improve after subthalamic (STN) stimulation after a marked reduction of dopaminergic medication. In order to investigate the effect of STN stimulation on impulsive decision making, we used the Iowa Gambling task (IGT). Methods We investigated IGT performance in 20 patients with PD before STN surgery with and without dopaminergic treatment and in 24 age-matched controls. All patients underwent an extensive neuropsychological interview screening for behavioural disorders. Assessment in patients was repeated 3 months after surgery without dopaminergic treatment with and without stimulation. Results Chronic antiparkinsonian treatment was drastically reduced after surgery (−74%). At baseline, on high chronic dopaminergic treatment 8/20 patients with PD presented with pathological hyperdopaminergic behaviours, which had resolved in 7/8 patients 3 months after surgery on low chronic dopaminergic treatment. Preoperative performance on the IGT was significantly impaired compared to after surgery. Conclusions Dopaminergic medication likely contributes to the impairment in decision making underlying ICDs. Deep brain stimulation allows drastic reduction of dopaminergic medication and, thus, concomitant remediation of medication-induced impairment in decision making.

[1]  Paul Krack,et al.  Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. , 2013, Brain : a journal of neurology.

[2]  J. Régis,et al.  Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[3]  J. Kulisevsky,et al.  Apathy in Parkinson's Disease: More Than Just Executive Dysfunction , 2013, Journal of the International Neuropsychological Society.

[4]  P. Pollak,et al.  Psychostimulant effect of levodopa: reversing sensitisation is possible , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[5]  Eric Seigneuret,et al.  Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours. , 2012, Brain : a journal of neurology.

[6]  U. Bonuccelli,et al.  Iowa gambling task in de novo Parkinson's disease: A comparison between good and poor performers , 2012, Movement disorders : official journal of the Movement Disorder Society.

[7]  Michael S. Okun,et al.  Effects of STN and GPi Deep Brain Stimulation on Impulse Control Disorders and Dopamine Dysregulation Syndrome , 2012, PloS one.

[8]  A. Lang,et al.  Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. , 2011, Archives of neurology.

[9]  A. Lang,et al.  Impulse control disorders in parkinson disease: A multicenter case–control study , 2011, Annals of neurology.

[10]  Y. Shimo,et al.  Acute effects of bilateral subthalamic stimulation on decision-making in Parkinson's disease. , 2011, Parkinsonism & related disorders.

[11]  C. Winstanley,et al.  Lesions of the Basolateral Amygdala and Orbitofrontal Cortex Differentially Affect Acquisition and Performance of a Rodent Gambling Task , 2011, The Journal of Neuroscience.

[12]  N. Volkow,et al.  Neurocircuitry of Addiction , 2010, Neuropsychopharmacology.

[13]  P. Calabresi,et al.  Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap , 2010, The Lancet Neurology.

[14]  S. Houle,et al.  Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD , 2010, Neurology.

[15]  U. Bonuccelli,et al.  Decision making in de novo Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[16]  L. Tremblay,et al.  Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. , 2010, Brain : a journal of neurology.

[17]  M. Merello,et al.  Decision‐making in Parkinson’s disease patients with and without pathological gambling , 2010, European journal of neurology.

[18]  A. Lawrence,et al.  Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson’s disease , 2009, Journal of Clinical Neuroscience.

[19]  E. Tolosa,et al.  Neuroanatomical correlates of impaired decision‐making and facial emotion recognition in early Parkinson’s disease , 2009, The European journal of neuroscience.

[20]  M. Delazer,et al.  Decision making under risk and under ambiguity in Parkinson's disease , 2009, Neuropsychologia.

[21]  T. Robbins,et al.  Review Personality, Addiction, Dopamine: Insights from Parkinson's Disease Table 1. Possible Site of Striatal Dopamine Dysfunction Causing Different Motor and Cognitive Symptoms in Parkinson's Disease , 2022 .

[22]  A. Strafella,et al.  Dopamine Agonists Diminish Value Sensitivity of the Orbitofrontal Cortex: A Trigger for Pathological Gambling in Parkinson's Disease? , 2009, Neuropsychopharmacology.

[23]  A. Antonini,et al.  Functional abnormalities underlying pathological gambling in Parkinson disease. , 2008, Archives of neurology.

[24]  T. Robbins,et al.  Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making , 2008, Brain : a journal of neurology.

[25]  Masaru Mimura,et al.  Decision making in Parkinson's disease: Analysis of behavioral and physiological patterns in the Iowa gambling task , 2008, Movement disorders : official journal of the Movement Disorder Society.

[26]  J. Kulisevsky,et al.  Controlled study of decision‐making and cognitive impairment in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[27]  M. D’Esposito,et al.  Reversal learning in Parkinson's disease depends on medication status and outcome valence , 2006, Neuropsychologia.

[28]  Yen F. Tai,et al.  Compulsive drug use linked to sensitized ventral striatal dopamine transmission , 2006, Annals of neurology.

[29]  M. Mimura,et al.  Impaired decision-making in Parkinson's disease. , 2006, Parkinsonism & related disorders.

[30]  A. Bechara Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective , 2005, Nature Neuroscience.

[31]  Y. Agid,et al.  Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson’s disease? , 2005, Journal of Neurology Neurosurgery & Psychiatry.

[32]  C. Tanner,et al.  Levodopa and the progression of Parkinson's disease. , 2004, The New England journal of medicine.

[33]  A. Benabid,et al.  Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 2003, The New England journal of medicine.

[34]  R. Hilker,et al.  Activation of basal ganglia loops in idiopathic Parkinson’s disease: a PET study , 2003, Journal of Neural Transmission.

[35]  Laura Bellodi,et al.  Decision-making heterogeneity in obsessive-compulsive disorder: ventromedial prefrontal cortex function predicts different treatment outcomes , 2002, Neuropsychologia.

[36]  B. Dubois,et al.  Motivation, reward, and Parkinson’s disease: influence of dopatherapy , 2002, Neuropsychologia.

[37]  Roberto Keller,et al.  Frontal lobe dysfunction in pathological gambling patients , 2002, Biological Psychiatry.

[38]  T. Robbins,et al.  Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. , 2001, Cerebral cortex.

[39]  T. Robbins,et al.  Probabilistic learning and reversal deficits in patients with Parkinson’s disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication , 2000, Neuropsychologia.

[40]  Y. Agid,et al.  Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible? , 2000, Annals of neurology.

[41]  A. Damasio,et al.  Insensitivity to future consequences following damage to human prefrontal cortex , 1994, Cognition.

[42]  S. Kish,et al.  Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.